SEARCH RESULTS FOR: "Tag: imgo"
loading image
REFINE YOUR SEARCH:
RECENT
Last Month(1)
ARTICLES/BLOGS
2022(1)
CATEGORIES
Analyst Update(1)

11/21/2022 9:05 AM
Merck & Co., Inc. (NYSE:MRK) is set to acquire biopharmaceutical company Imago Biosciences Inc (NASDAQ:IMGO) in a cash deal worth $1.35 billion. Merck will pay $36 per share, or a 106.9% premium to I...
PEOPLE ALSO SEARCH FOR